A tracer kinetic procedure was developed for the measurement of monoamine oxidase type B (MAO-B) activity using L-[llCldeprenyl and positron emission to mography (PET). The kinetic model consisted of two tis sue compartments with irreversible binding to the second compartment (three rate constants). In addition, a blood volume component was included. Special attention was given to the accurate measurement of the plasma and whole blood input functions. The method was applied to the measurement of the dose-response curve of a revers-Recent reports have related administration of L deprenyl [( -)-N,a-dimethyl-N-2-propynylphene thylamine], a selective irreversible inhibitor of monoamine oxidase type B (MAO-B) (Knoll and Magyar, 1972; Sourkes, 1983) , to delayed progress of Parkinson's disease (Tetrud and Langston, 1989; The Parkinson Study Group, 1989). Clearly, a method for measuring MAO-B activity in vivo would be useful in optimising the administered dose of L-deprenyl and other newly developed reversible MAO-B inhibitors.
develop a tracer procedure for L-e 'C]deprenyl that would allow for more quantitative measurements of MAO-B activity. The method was assessed by mea suring the dose-response curve of Ro 19-6327 [N (2-aminoethyl)-5-chloro-2-pyridine carboxamide HCl], a reversible, highly selective inhibitor of MAO-B (Da Prada et ai. , 1988) . A more detailed description of this dose-response measurement and a correlation with platelet binding can be found elsewhere (Bench et aI. , 1991) . The present report concentrates on the underlying method.
METHODS

Subjects
Eight normal subjects (three female, five male) with an age ranging from 55 to 71 years were studied. One subject was studied after an oral predose of 20 mg of L-deprenyl and six subjects after varying oral predoses (1 �50 mg) of Ro 19-6327, 12 h before scanning. One subject did not receive any predose.
All normal subjects gave their informed consent prior to scanning. The studies were approved by the Research Ethics Committee of Hammersmith Hospital. Permission to administer the radioactive tracers was obtained from the United Kingdom Administration of Radioactive Sub stances Advisory Committee.
Scanning protocol
After insertion of a 22G cannula into the radial artery, subjects were positioned in an ECAT 931-08/12 (Cn, Knoxville, TN, U.S.A.) positron emission tomograph (Spinks et aI., 1988) . Head, movement was restricted by individual moulded polystyrene head supports.
Following acquisition of a transmission scan of average count density of 16 x 106 counts/plane, for the purpose of attenuation correction, each subject received a bolus in travenous injection of a saline solution of L e'C]deprenyl. The injected dose was on average (±SD) 8.23 ± 3.06 mCi, with a specific radioactivity ranging from 70 to 340 mCi/lJ-mol. The weight of the injected dose ranged from 6.2 to 17.llJ-g. L-["C]deprenyl was prepared by alkylation of the N-dimethyl compound with ["CJmethyl iodide as described previously (Fowler et aI., 1987) .
Starting at the time of injection, 48 sequential dynamic scans (frames) were collected over a period of 90 min according to the following protocol: 24 x 5 s, 4 x 30 s, 6 x 60 s, 4 x 150 s, 6 x 300 s, and 4 x 600 s.
Arterial whole blood was withdrawn continuously from the radial artery cannula at a rate of 5 mllmin for at least \0 min. At that time, the withdrawal rate was reduced to 2.5 ml/min except for the three lightest subjects, where withdrawal was stopped. The on-line detection system was identical to that described previously (Lammertsma et aI., 1990) except that the plastic scintillator was re placed by a bismuth germanate (BGO) crystal. This de tection system was cross-calibrated against the PET scan ner and a well counter used for the measurement of dis crete blood samples. To increase sensitivity, both the 511 and 1,022 ke V peaks were used for monitoring the blood concentration. Shielding of the detector was such that room background was negligible.
At set times (5, 10, 15, 20, 35, 45, 60, 75 , and 90 min after injection), continuous blood withdrawal was inter rupted for the collection of blood samples from a three way tap positioned directly behind the BGO detector. Both whole blood and plasma concentrations of these samples were measured using the well counter. After each sample, the arterial line was flushed with heparin ised saline. The samples collected at 5, 10, 15, and 20 min postinjection were also analysed for L-["C]deprenyl me tabolites as described elsewhere (Bench et aI., 1991) . In one subject, neither continuous blood data nor sampling data were available from 40 min onwards due to a blocked cannula.
Input functions
To obtain accurate input functions for kinetic analysis, a number of modifications to the measured arterial blood curve were performed.
First, the measured arterial whole blood curve was cor rected for dead time, calibrated, and corrected for decay. However, it was clear that a significant degree of sticking of activity to the wall of the detector tubing occurred. To correct for this sticking (and dispersion), the following procedure was adopted: First, the blood curve between 5 and 90 min (i.e., between first and last discrete samples) was fitted to a multiexponential function. Starting with a single exponential function, additional exponentials were added until the Akaike information criterion (Akaike, 1974) or the Schwarz criterion (Schwarz, 1978) indicated no further improvement. The resulting multiexponential function was then used to calculate total concentration J Cereb Blood Flow Metab, Vol. 11, No. 4, 1991 levels at the times of the discrete samples. The difference of these interpolated values with the actual measured (whole blood) sample values was considered to reflect the contribution of sticking activity. These "sticking activity" values were then fitted to a "single tissue compartment" model (i.e., two rate constants) using the original continuous blood curve as an input function. The two rate constants obtained in this manner were in turn used to correct the original blood curve for sticking ac tivity. The process of compartmental fitting and subse quent correction of the blood curve for sticking activity was repeated until both rate constants were constant within 0.1%, resulting in an arterial whole blood curve corrected for sticking activity.
Second, the total arterial plasma time-activity curve was obtained according to the following procedure: For each discrete sample, the plasma to whole blood ratio was calculated. In addition, based on in vitro experiments, it was assumed that the initial distribution of L-["C]de prenyl was similar to the water space, i.e., the plasma to whole blood ratio was assumed to be 1.126 at the time of arrival of the tracer in the blood (taken to be the time where the blood curve increased above 1 % of the peak value). The ratio of 1.126 was the average value for 200 steady state CJ502 studies. The ratio of plasma to whole blood concentrations was then fitted to a multiexponen tial function. Again, the number of exponentials was based on the Akaike and Schwarz criteria (Akaike, 1974; Schwarz, 1978) . The total plasma curve in turn was ob tained by multiplying the (corrected) whole blood curve with this multiexponential function.
In the three studies where continuous blood withdrawal was stopped between \0 and 15 min, the same procedures were applied to the measured blood curve. The (cor rected) whole blood curve and (total) plasma curve were then extended using the values obtained from the discrete samples at later times.
Finally, the arterial plasma curve of unchanged L [1'C]deprenyl was obtained by fitting the fraction of me tabolites to a single exponential function, assuming no metabolites at time 0 and 100% at infinite time.
Image analysis
All emission scans were reconstructed using a Hanning filter with a cutoff frequency of one-half of the maximum. This resulted in a spatial resolution of 8.4 x 8.3 x 6.6 mm FWHM (full width at half-maximum) at the centre of the field of view (Spinks et aI., 1988) .
After reconstruction, the dynamic images were trans ferred to a workstation (Model 3/60, Sun Microsystems, Mountain View, CA, U.S.A.). Whole brain regions of interest (ROIs) were defined on all of the 15 collected planes. Tissue time-activity curves were generated by projecting these ROls onto the 48 dynamic frames. The average of these 15 time-activity curves was used as the whole brain tissue response curve. In a similar fashion, average tissue response curves were defined for cortex (frontal, temporal, and occipital), basal ganglia (caudate and putamen), thalamus, and white matter (centrum semi ovale). One of the studies was omitted from this regional analysis because of noise due to the very low dose of radioactivity administered (2.4 mCi).
Tracer model
Based on the irreversible character of L-deprenyl bind ing, the two tissue compartment model illustrated in Fig was taken as a starting point. The model contained three rate constants to account for transfer of L-[ ] ] Cjdeprenyl from (metabolite corrected) plasma to tissue (K ] ) and vice versa (kz) and for binding to . It was assumed that the kinetics between free and possible not specifi cally bound (i.e., not bound to MAO-B) L-[ ]] Cjdeprenyl in tissue was fast so that it could be characterised by one compartment.
Since the signal registered from an ROI will always contain some intravascular activity, blood volume (Vb)
was added as an additional model parameter. It should be noted that for the blood volume parameter, not the arte rial plasma (Cp) but the (corrected) arterial whole blood (Ca) curve was required as an "input function."
The measured "tissue" concentration within an ROI (C ROI) can then be described by where the actual tissue concentration (C,) is given by
with * representing the convolution integral.
Kinetic analysis
U sing the arterial whole blood-and metabolite corrected arterial plasma curves, the whole brain time activity curves were fitted for K ] , k2' k3' Vb' and delay of the blood curves using Eqs. (1) and (2) and a standard nonlinear regression technique. The additional delay pa rameter was required because the arrival of activity in the external blood detection system was delayed compared to that in the brain (Lammertsma et aI., 1990) . Time-activity curves for the smaller ROls were then fitted with the delay fixed to the value obtained from the whole brain analysis. Dose response curves were generated both for k3 (rate constant for specific binding) and Ki [net influx constant = K]kAkz + k3)J.
The whole brain curves were refitted with a similar reversible model containing a fourth rate constant k4 (transfer from bound to free). In addition, a graphical analysis (Patlak et aI., 1983 ) was applied to the whole brain data. These two analyses were performed in order to check if the data could indeed be described by an ir reversible model.
Stability of the results was tested by deleting a progres sive number of time frames from the end of the whole K1 specifically 777" ""+----i� bound k2 k3 brain time-activity curves and refitting the resulting (shorter) curves.
Correlation with CBF
In order to assess the relationship of k3 and Ki with CBF, an additional study in a normal volunteer, without any predosing, was combined with a measurement of CBF as described previously (Lammertsma et aI., 1990) . In this study, 49 different ROIs were defined according to anatomical structures. Each ROI was analysed both in terms of k3 and Ki, as described above. These values of k3 and Ki were correlated with the corresponding CBF val ues.
RESULTS
A typical blood curve, as measured by the exter nal detection system, is shown in Fig. 2 (solid line) . The "dips" in the curve correspond to the time points where manual samples were collected and the entire arterial line was flushed. The dashed line in Fig. 2 represents the best fit for the amount of activity sticking to the detector tubing. The (cor rected) whole blood curve is shown in Fig. 3 to gether with the total plasma curve (including me tabolites). In these curves, the flushing periods have been deleted.
In Fig. 4 , the metabolite-corrected plasma curve is compared to the whole brain ROI time-activity curve for the tracer alone study. Rapid clearance from the plasma and maintained activity within the brain are evident. The best fit to these data points, according to the model described above, is shown in Fig. 5 together with a similar analysis for one of the predosed studies, where the washout compo nent is seen to be more pronounced.
In Fig. 6 , data points and best fits are shown for (cortical) grey and (centrum semiovale) white mat ter for a predosed study. In these (regional) fits, the delay of the blood curves was fixed to the fitted value obtained from the whole brain analysis. Re fitting these curves with free delay (i. e. , as a param eter of the fit) did not improve the quality of the fits
� min significantly nor did it affect the values for K 1 to k3• Inclusion of a k4 parameter in whole brain or re gional fits also did not provide significantly better fits according to Akaike (Akaike, 1974) and Schwarz (Schwarz, 1978) criteria and the F statistic (Hawkins et aI. , 1986) . This was confirmed by a graphical analysis of the data. Linearity of the graph shown in Fig. 7 for a whole brain ROI is indicative of irreversible binding (Patlak et aI. , 1983) .
Results for the whole brain ROIs using the model of Fig. I (no k4) are given in Table 1 together with Ro 19-6327 dose information. The entire 90 min of data collection were used, except for the study where the cannula became blocked after 40 min. In Table 2 , k3 and Ki data are given for the regional analysis, except for the study with an injected dose of 2.4 mCi, which was not analysed regionally.
The values of whole brain k3 as a function of study duration are shown in Fig. 8 . Stable results are obtained for study durations longer than 20 min.
The solid line is the same arterial whole blood curve shown in Fig. 2 , now corrected for sticking activity. The dashed line is the total plasma curve (Le., not corrected for metabo lites). The plasma peak is ap proximately 10% higher than the whole blood peak. Note that the sampling and flushing peri ods have been deleted from the curves. For clarity, only the first 20 min of the curves are shown. 
Similar results were obtained for K), k2' Vb' and delay.
The Ro 19-6327 dose response curve for whole brain k3 is given in Fig. 9 and that for whole brain Kj Fig. 10 . It is clear that the dose of Ro 19-6327 is better related to the reduction of k3 than that of Kj• No relation was observed between dose of Ro 19-6327 and K), k2' and Vb' The dose response curve for cortical k3' given in Fig. t 1, is similar to that for whole brain k3• Analysis of the 20 30 40 50 60 70 80 90 min smaller regions was less successful. Although the dose-response curves showed a similar pattern, more scatter was observed (Table 2) presumably due to the higher noise levels in these smaller struc tures for studies at the lower range of the injected doses of L-[ II C]deprenyl. In Figs. 12 and 13, k3 and Kj, respectively, are plotted as functions of CBF for the additional tracer alone study where also CBF was measured. No relationship between k3 and CBF was observed, as demonstrated in Fig. 12 . How- :
Cortical grey (0) and centrum semiovale white ( * )
matter curves for the predosed study shown in Fig. 5 . Again, the lines represent best fits accord ing to the same model, but now with the delay of the blood curves fixed to the value ob tained from the whole brain fit shown in Fig. 5 . 90 min ever, Ki appeared to be correlated with CBF ( Fig.  13) .
DISCUSSION
Quantitative analysis of PET data not only re quires accurate measurement of the tissue response curves, but also of the (blood) input functions. In the present study, special attention was given to measuring both whole blood and plasma curves, since both are required in the compartmental de scription of ROl data, with plasma providing the input to tissue and whole blood acting as a "back ground" signal within an ROI. firms that the data can be de scribed by an irreversible pro cess (Patlak et aI. , 1983) . 0.344 ± 0.008 0.353 ± 0.017 0.152 ± 0.003 0.189 ± 0.004 0.051 ± 0.001 0.017 ± 0.001 0.028 ± 0.001 0.030 ± 0.001 551 K; (ml ml-I min-I) 0.272 ± 0.001 0.192 ± 0.001 0.185 ± 0.001 0.264 ± 0.001 0.119 ± 0.001 0.044 ± 0.002 0.071 ± 0.001 0.066 ± 0.001 errors associated with these fast sampling proto cols, preference was given to continuous blood withdrawal. The relative slow change of the blood curve at later times indicates, however, that there is no significant loss of accuracy in the three studies where continuous blood withdrawal was stopped af ter 10 min.
For monitoring the arterial concentration, a sim ilar system as previously described (Lammertsma et aI., 1990) was used. Only one modification was introduced: the plastic scintillator was replaced by a BGO crystal based on its higher efficiency for counting lIC. It is also less sensitive to small changes in tubing geometry. Therefore, it is possi ble to calibrate the detection system independent of the actual study. A plastic scintillator would have required on-line calibration.
from the periods of flushing in that the detected levels of activity did not return to negligible values (Fig. 2) . In addition, the interpolated curve values during these periods were much higher than the whole blood sample values. Sticking was confirmed by experiments where a tube was filled with L [11C]deprenyl and the activity measured in a well counter. After rigorous flushing and recounting, the level of remaining activity was still 3.5% of the orig inal. The latter part of the blood curve (Fig. 2) will therefore contain a significant contribution of resid ual sticking activity from the peak.
One problem associated with the on-line detec tion system was the high level of sticking of L [llC]deprenyl to the tube wall. This was evident
The compartmental analysis adopted to correct for this sticking fraction allowed not only for "binding" but also for "release." It is reassuring to note that the fit of the sticking fraction, based on the difference between sample and interpolated curve values, agrees with the minima of the flushing peri ods (Fig. 2) . It should also be realised that, although the correction for sticking activity was large, the FIG. 8. Values of whole brain k3 as a function of study duration for all eight studies. final accuracy of the blood curve was determined by the discrete calibration samples. The correction procedure basically forces the corrected continuous blood curve through the measured values obtained from the discrete samples. Although continuous withdrawal could be stopped at later times, a pro cedure followed in three of the studies, without sig nificant loss of accuracy with respect to the tail of the blood curve, preference was given to continuing 60 70 80 90
withdrawal. This allowed for a more detailed de scription of the kinetics of sticking (and dispersion), which in turn should provide a more accurate back extrapolation of the sticking fraction during the ini tial (peak) phase of the curve. Finally, since the discrete samples are used as reference points, the possible occurence of metabolites with different sticking properties than L-[IIC]deprenyl are un likely to affect the accuracy of the correction at later times. Nevertheless, it is clear that the pres ence of sticking is not desirable. In the present study, standard medical polythene tubing was used. Preliminary studies have shown that the degree of sticking can be greatly reduced by using polytet rafluoroethylene tubing. An alternative to a bolus injection with continu ous blood withdrawal would have been a slow infu sion of L-e iC]deprenyl with collection of discrete samples throughout the study. However, since the tracer is rapidly metabolised, this would have re sulted in significant metabolite levels during the peak of the curve, requiring more frequent estima tions of plasma metabolite levels. The total plasma curve was obtained by fitting the plasma to whole blood ratio values of the blood samples to a multiexponential function. In order not to disturb registration of the peak of the curve, the first blood sample was not collected until 5 min after injection. Therefore, an assumption had to be made regarding the plasma to whole blood ratio at time of injection. Based on in vitro exeriments, it was as sumed that the initial distribution of L-[ llC]deprenyl was similar to the water space. Based on 200 steady-state CJ502 (water) studies, this initial ratio was fixed to 1.126. This ratio value does not seem inappropriate since the ratio values of the 5 min samples ranged from 1. 1 to 1.2. It should be noted that an error in this ratio at early times will affect the peak height of the plasma curve. Consequently, KJ (and thus K) will be affected more than k3• There was more variation in the plasma to whole blood ratio at the latter part of the 90 min study period, ranging from 0.8 for the tracer alone study to about CBF (ml/ml/min) 1. 1 for the studies with the lowest k3• This is con sistent with inhibition of L-e IC]deprenyl uptake by blood cells.
To obtain the true tissue input function, the plasma curve had to be corrected for IIC-labeled metabolites. This correction inherently assumes that the labeled metablites do not cross the blood brain barrier. This assumption is based on the fact that the metabolites of L-deprenyl are much more polar than L-deprenyl itself. One problem in mea suring plasma metabolite levels was the rapid clear ance from the plasma (Figs. 3 and 4) , resulting in low levels of activity. In practise, it was only fea sible to determine metabolite levels for the first four samples (i.e., up to 20 min) and consequently in growth of metabolites for the remaining period had to be estimated by extrapolation. In the present study, this was achieved by fitting a single expo nential function through the metabolite fraction, as suming no metabolites at time zero and 100% at infinity. The latter assumption seems reasonable given the observation that the metabolite fraction at 20 min was high (50 to 85%). Nevertheless, it has to be said that the applied metabolite correction pro cedure is potentially the most uncertain step in the present analysis.
To test the sensitivity of k3 and Ki estimates to possible errors in the extrapolation procedure, the tracer alone study and one of the predosed studies were reanalysed with metabolite-corrected plasma curves generated with the assumption that the me tabolite level at infinity was 90% instead of 100%. In effect, this would result in a 10% different metabo lite level at the end of the study. Refitting the data over the entire 90 min study period resulted in un changed Ki values and in k3 values that were only 5% lower. However, both Ki and k3 values re mained unchanged for 10 and 30 min analysis peri ods. Therefore, the stability of the results for vary ing study durations (Fig. 8 ) did provide some evi dence of the adequacy of the various corrections applied to the input functions as well as the correct ness of the tracer model used. If one of the correc tions, in particular the metabolite correction, had been wrong, the magnitude of its error would most likely have been a function of time. From Fig. 8 , it follows that results were stable for study durations ranging from 10 to 90 min. The fitted parameters only varied significantly for study durations of less than 10 min. This variation can easily be explained by the lack of temporal information for character ization of a two tissue compartment model, since "equilibration" of the tissue curves has not been achieved within 10 min (Figs. 4 to 6) .
L-deprenyl is known to be an irreversible inhibi-tor of MAO-B (Knoll and Magyar, 1972; Sourkes, 1983) . Irreversible uptake of L-e IC]deprenyl has previously been demonstrated by Fowler et al. (1987) . Linearity of the graphical analysis as dem onstrated in Fig. 7 confirmed this finding (Patlak et aI., 1983) . In addition, inclusion of a k4 parameter did not improve the quality of the fits nor the values of K I to k3 significantly. The Ro 19-6327 dose-response curve for whole brain Ki (Fig. 10) showed considerable more scatter than that for whole brain k3 (Fig. 9) . However, it should be realised that two of the studies were not optimal. For the study following a predose of 0.114 mg/kg, only 40 min of the data could be used due to a blocked cannula. The study following a predose of 0.477 mg/kg was statistically limited due to the low injected dose of 2.4 mCi. Nevertheless, even if these two studies are omitted, the k3 dose-response curve shows slightly less scatter.
From a physiological point of view, k3 is also to be preferred. It directly provides the rate of bind ing, while Ki is "contaminated" with a variable flow component. If the rate of binding is high (k2 < < k3), Ki approaches K I • In the case of strong inhibition (k2» k3), however, Ki becomes Klk3/k2' This was confirmed in a separate study, where k3 and Ki for various ROIs were correlated with CBF. It was shown that k3 was independent of CBF ( Fig. 12) , but that Ki, even for this tracer alone study, was correlated to some extent with CBF. Since all ROIs were defined in the same study, these findings were independent of possible systematic errors in the ma nipUlations of the input function.
With respect to regional analysis, a satisfactory dose-response curve (Fig. II) could be generated for cortical grey matter (excluding the study with a dose of 2. 4 mCi). For the smaller ROls, similar pat terns were observed, although too much scatter was present to produce reliable dose-response curves. This was mainly due to noise in the data resulting from low injected doses of radioactivity, reflected in some high standard errors in the fitted values of k3 (Table 2 ). However, it is possible to obtain re gional results (Fig. 6) provided a sufficient amount of L-e IC]deprenyl is injected (> 10 mCi).
CONCLUSIONS
Using PET and L-lIIC]deprenyl, it was possible to measure the dose-response curve of a reversible MAO-B inhibitor. However, the rate constant for binding (k3) seemed to provide more accurate re sults than the blood to brain influx constant (KJ This implies that for a reliable assessment of MAO B activity, full kinetic analysis would be required.
The present study demonstrates the feasibility of this approach, provided sufficient attention is being paid to the determination of the plasma input func tion.
The method presented for the measurement of both whole blood and plasma time-activity curves is potentially applicable to a variety of tracer stud ies. Only a limited number of blood samples is re quired and all correction procedures can be auto mated.
